Diseases & Disorders
(G30)
IRS Verified
DX Registered
990 on File
ABCD INC
Financial strength (30%)
77/100
Reliability (20%)
55/100
Effectiveness (25%)
93/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Mission Statement
ABCD: After Breast Cancer Diagnosis nurtures hope and restores confidence in all those affected by breast cancer. We provide free, personalized information and one-to-one support to patients, families and friends affected by breast cancer, from the newly diagnosed to those in treatment and on into survivorship.
Financial Overview — FY 2025
$1.3M
Total Revenue
$1.1M
Total Expenses
$1.3M
Net Assets
8
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
80.4%
Fundraising Efficiency
379.7%
Operating Reserve
13.35x
Liability-to-Asset
2.7%
Revenue Diversification
96.2%
Executive Compensation
$161K
Compared with Peers
FY 2025
Compared with 336 similar organizations
(United States, Diseases & Disorders, $1M–$10M in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
80.4% | 82.1% |
P10P90
|
Below median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
8.1% | 11.1% |
P10P90
|
Above median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
11.5% | 3.1% |
P10P90
|
Bottom quarter |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
379.7% | 114.8% |
P10P90
|
Bottom quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
13.4 mo | 12.8 mo |
P10P90
|
Above median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
2.7% | 12.5% |
P10P90
|
Top quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
96.2% | 87.6% |
P10P90
|
Below median |
|
Revenue growth
Year over year revenue growth
|
13.7% | 6.7% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
21.3% | 6.5% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
14.5% | 3.9% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $1.3M | $1.1M | $1.3M | 80.4% | 8 |
| 2024 | $1.2M | $929K | $1.0M | 78.7% | 7 |
| 2023 | $761K | $778K | $797K | 80.3% | 5 |
| 2022 | $808K | $981K | $741K | 77.5% | 7 |
| 2021 | $893K | $735K | N/A | — | 7 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.